Is Artiva Biotherapeutics a good buy right now?
USNASDAQ: ARTVNASDAQ-listedlast $7.78 · 20 May 2026
Not yet — wait
Signal paused. ARTV's price history has a jump — most likely a split or bonus issue that was not adjusted — and 4 trades touching it were left out until the data is checked. The last Buy signal came on 28 Apr 2026 at $9.08 and closed on 20 May 2026 (−14.3%).
As of 30 Sep 2026 · Firefly Breakout Weekly
What happened after the last 8 buy signals on ARTV
Oct 2024 – 30 Sep 20261 of 8 closed above the entry price, with an average outcome of −4.7% per signal before costs; a signal typically stayed open about 3 d. 4 trades touching a jump in the price data were left out.
| Buy signal | Price then | Closed | Held | Outcome |
|---|---|---|---|---|
| 28 Apr 2026 | $9.08 | 20 May 2026 | 3 wk | -14.3% |
| 23 Apr 2026 | $11.17 | 28 Apr 2026 | 5 d | -22.2% |
| 16 Apr 2026 | $9.21 | 20 Apr 2026 | 4 d | +57.2% |
| 15 Apr 2026 | $9.13 | 15 Apr 2026 | 1 d | -14.0% |
| 11 Mar 2026 | $7.4 | 13 Mar 2026 | 2 d | -10.9% |
| 11 Oct 2024 | $16.59 | 11 Oct 2024 | 1 d | -10.1% |
| 2 Oct 2024 | $16.48 | 7 Oct 2024 | 5 d | -11.4% |
| 1 Oct 2024 | $17.31 | 1 Oct 2024 | 1 d | -11.8% |
Outcomes are simulated by applying Firefly's rules to historical prices, before costs and slippage. Sell triggers are not counted: Firefly reads them as “don't enter”, not as short trades. Past behaviour of a rule is not a prediction of future prices.
The strategy behind this page
one rule set per market · beta| Strategy | Horizon | Signal | Since | Buy signals closed higher |
|---|---|---|---|---|
| Firefly Breakout Weekly | Medium term | No signal | — | 13% |
This beta publishes one rule set per market — Firefly Breakout Weekly — chosen in the October 2026 review. What the beta shows and how the data was cleaned →
Same theme beyond US
same theme, other marketsIndian peers are listed on the NSE and priced in rupees. Crypto gains are taxed at 30% in India with 1% TDS. Shown for context — not a recommendation to switch markets.
More questions about ARTV
ARTV share price today — buy or sell?
As of 30 Sep 2026, Firefly Breakout Weekly says wait on Artiva Biotherapeutics. Signal paused. ARTV's price history has a jump — most likely a split or bonus issue that was not adjusted — and 4 trades touching it were left out until the data is checked. The last Buy signal came on 28 Apr 2026 at $9.08 and closed on 20 May 2026 (−14.3%). The last price on record was $7.78 on 20 May 2026.
How has Firefly's strategy done on Artiva Biotherapeutics?
From October 2024 to 30 Sep 2026 Firefly's rules gave 8 buy signals on Artiva Biotherapeutics; 1 closed above the entry price and the average outcome was −4.7% per signal, simulated on historical prices before costs. A handful of signals is a pattern, not a statistic.
What is the Artiva Biotherapeutics price target?
We don't publish price targets — no rule-based system can forecast a price. Firefly Breakout Weekly closes each signal by its own rules; every closed signal on Artiva Biotherapeutics and how it turned out is listed on this page.
Should I sell Artiva Biotherapeutics?
No sell trigger is active on Artiva Biotherapeutics as of 30 Sep 2026. This describes a rule, not advice on your position.
Why does this page show a single strategy?
This is the Signals beta. Each market publishes one rule set — here Firefly Breakout Weekly — instead of a vote across Firefly's whole library, and the verdict is its signal as of 30 Sep 2026. Sell triggers count as “don't enter”; only buy triggers are scored.
Fintrens shows how one of Firefly's rule-based strategies reads this stock. It is educational information, not investment advice and not a recommendation to buy or sell. We do not publish price targets. Indian residents buy US stocks under the RBI's Liberalised Remittance Scheme; tax is collected at source above the annual threshold. Read how Firefly's strategies work →